Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,360.00
Bid: 11,850.00
Ask: 12,470.00
Change: 0.00 (0.00%)
Spread: 620.00 (5.232%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 12,360.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

FTSE 100 movers: Lloyds declines as state investment vehicle lowers stake, miners lower

Mon, 01st Jun 2015 13:49

UK shares were trading lower on Monday afternoon, ahead of a raft of US economic data, as weakness in mining, oil and insurance stocks outweighed gains made in the real estate, travel and electronics sectors.As of 15:30 BST, the FTSE 100 was trading 0.23% lower at 6,988.Lloyds registered losses as UK Financial Investments, the state investment vehicle, lowered its stake to 18.99% from the 19.93% it held on 12 May. The move follows continued market speculation surrounding the timing public share-selling, with the aim of returning the lender wholly to private ownership, possibly as early as September.Morrison dipped ahead of this week's annual meeting, as investors are expected to object to former chief executive Dalton Phillips's substantial payoff. The company is also at risk of being removed from the FTSE 100 altogether, to be replaced by satellite communications group Inmarsat.Prudential was also weaker as it appointed Barry Stowe as chairman and chief executive of its North American business.Miners Fresnillo, Anglo American and Glencore were in the red following weak manufacturing data from China, the world's biggest metals consumer. Oil giants Weir Group and Shell also declined, as oil prices retreated from last week's highs.Shell was also hit with allegations that it tried to use its connections with the Science Museum to influence the presentation of its Climate Change programme. A leaked internal email expressed concerns that a particular part of the project sponsored by the company "creates an opportunity for NGOs [non-governmental organisations] to talk about some of the issues that concern them around Shell's operations".Astrazeneca was boosted by positive takeaways from the annual meeting of the American Society of Clinical Oncology, during which the company presented preliminary data for one of its lung cancer drugs.WPP was trading higher, despite reports that it could face opposition from shareholders at its annual meeting on 9 June over chief executive Martin Sorrell's £43m pay award for 2014. Glass Lewis and Institutional Shareholder Services (ISS), which advise investors that own about a quarter of the equities on the UK stock market, have both raised concerns about the 40% increase, according to The Financial Times.RisersAshtead Group (AHT) 1,155.00p +3.12%Dixons Carphone (DC.) 485.40p +2.10%International Consolidated Airlines Group SA (CDI) (IAG) 564.00p +1.81%British Land Company (BLND) 877.00p +1.74%St James's Place (STJ) 926.00p +1.59%Intertek Group (ITRK) 2,540.00p +1.56%InterContinental Hotels Group (IHG) 2,781.00p +1.46%Land Securities Group (LAND) 1,332.00p +1.45%Lloyds Banking Group (LLOY) 88.95p +1.34%Taylor Wimpey (TW.) 185.80p +1.25%FallersWeir Group (WEIR) 1,978.00p -2.27%Standard Chartered (STAN) 1,033.00p -1.24%Glencore (GLEN) 284.65p -1.15%Royal Dutch Shell 'B' (RDSB) 1,956.00p -0.89%Anglo American (AAL) 1,017.00p -0.88%Imperial Tobacco Group (IMT) 3,341.00p -0.86%Kingfisher (KGF) 366.90p -0.84%Barclays (BARC) 268.10p -0.70%Aggreko (AGK) 1,597.00p -0.68%Mondi (MNDI) 1,466.00p -0.68%
More News
3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsortix technology, opening the door for future clinical study-supporting contracts.

Read more
3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more
25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.

Read more
25 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover talks.

Read more
25 Apr 2024 10:33

AstraZeneca leaps after smashing first-quarter forecasts

Q1 revenue up 19% to $12.68 bln

*

Read more
25 Apr 2024 09:18

TOP NEWS: AstraZeneca upbeat as cancer drugs underpin sales growth

(Alliance News) - AstraZeneca PLC on Thursday hailed the potential of its drugs pipeline as it delivered impressive growth in sales and profit in the first quarter.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.